(15 days)
CT Colonography II is a CT image analysis software package which allows the visualization of 2D and 3D medical image data of the colon derived from DICOM 3.0 compliant CT scans for the purpose of screening of a colon to detect polyps, masses, cancers, and other lesions. It provides functionality for 2D/3D rendering, bookmarking of suspected lesions, synchronized viewing of the 2D, 3D and 360 dissection views, and an object oriented endoluminal display. In comparison to Colonoscopy, this tool has an advantage of depth penetration due to its 3D presentation capability. It is intended for use by Radiologists, Clinicians, and referring Physicians to process, render, review, archive, print and distribute colon image studies.
CT Colonography II is a CT image analysis software package which allows the visualization of 2D and 3D medical image data of the colon derived from DICOM 3.0 compliant CT scans for the purpose of screening of a colon to detect polyps, masses, cancers, and other lesions. It provides functionality for 2D/3D rendering, bookmarking of suspected lesions, synchronized viewing of the 2D, 3D and 360 dissection views, and an object oriented endoluminal display.
The provided text is a 510(k) summary for the GE Medical Systems CT Colonography II device. It describes the device, its indications for use, and its substantial equivalence to a predicate device. However, it does not contain any information regarding acceptance criteria or the study that proves the device meets those criteria.
Specifically, the document focuses on:
- Product Identification: Name, classification, manufacturer, distributor, and predicate device.
- Device Description: What the device is and its functions (visualization of 2D/3D medical image data of the colon, bookmarking, synchronized viewing, endoluminal display).
- Indications for Use: Screening of a colon to detect polyps, masses, cancers, and other lesions.
- Comparison with Predicate: States substantial equivalence to the CT Colonography (K023943).
- Adverse Effects on Health: Identifies potential hazards managed through software development, validation, verification processes, and adherence to standards.
- Conclusions: No new safety risks, performs as well as existing devices, equivalent to the predicate.
- FDA Clearance Letter: Official communication from the FDA confirming substantial equivalence.
Therefore, I cannot provide the requested table or additional information as the document does not contain the necessary data regarding acceptance criteria, performance studies, sample sizes, expert involvement, ground truth establishment, or comparative effectiveness details.
{0}------------------------------------------------
1270
MAY 27 2004
Image /page/0/Picture/2 description: The image shows the General Electric (GE) logo. The logo consists of the letters "G" and "E" intertwined within a circular border. The logo is black and white.
GE Medical Systems
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR Part 807.87(h).
Larry A. Kroger, Ph.D. Submitter Senior Regulatory Programs Manager Tel: (262) 544-3894 Fax: (262) 544-4768 GE Medical Systems W-400 3000 North Grandview Blvd. Waukesha, WI 53188 USA Date Prepared: February 20, 2004.
PRODUCT IDENTIFICATION
| Name: | CT Colonography II |
|---|---|
| Classification Name: | Accessory to Computed Tomography System |
| Manufacturer : | General Electric Medical Systems283, rue de la Minière78533 Buc Cedex, FRANCE |
| Distributor: | General Electric Medical Systems, Buc, France. |
| Marketed Devices | The CT Colonography II is substantially equivalent to the devices listed below |
| Model: | CT Colonography |
General Electric Medical Systems, Buc, France Manufacturer: K023943 510(k) #:
Device Description:
CT Colonography II is a CT image analysis software package which allows the visualization of 2D and 3D medical image data of the colon derived from DICOM 3.0 compliant CT scans for the purpose
{1}------------------------------------------------
Indications for Use:
CT Colonography II is a CT image analysis software package which allows the visualization of 2D and 3D medical image data of the colon derived from DICOM 3.0 compliant CT scans for the purpose of screening of a colon to detect polyps, masses, cancers, and other lesions. It provides functionality for 2D/3D rendering, bookmarking of suspected lesions, synchronized viewing of the 2D, 3D and 360 dissection views, and an object oriented endoluminal display. In comparison to Colonoscopy, this tool has an advantage of depth penetration due to its 3D presentation capability. It is intended for use by Radiologists, Clinicians, and referring Physicians to process, render, review, archive, print and distribute colon image studies.
Comparison with Predicate:
The functional features of the CT Colonography II software package are substantially equivalent to that of the following device:
| Device Name------------------------------------------------------------------------------------------------------------------------------------------------------------------------------and answer of the control of change of channer of consection of the | FDA Clearance Number |
|---|---|
| CT Colonography | Comments of the first and the commended to the comments of the comments of the comments of the comments of the comments of the comments of the comments of the comments of theK023943 |
Adverse Effects on Health:
The potential hazards are identified in a risk management summary (hazard analysis) and are controlled by:
- · Software Development, Validation and Verification Process to ensure performance to specifications, Federal Regulations and user requirements.
- · Adherence to industry and international standards.
Conclusions:
The CT Colonography II does not result in any new potential safety risks and performs as well as devices currently on the market. GE considers features of the CT Colonography II to be equivalent to those of CT Colonography (K023943).
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three tail feathers, representing the department's mission to protect the health of all Americans and provide essential human services. The eagle is encircled by the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement.
Public Health Service
NAR 1 1 2009
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
General Electric Medical System % Mr. Tamas Borsai Program Manager 510(k) Review TUV Rheinland of North America, Inc. Medical Division, Newton Office 12 Commerce Road NEWTON CT 06470
Re: K041270 Trade/Device Name: CT Colonography II Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: NWE Dated: May 3, 2004 Received: May 12, 2004
Dear Mr. Borsai:
This letter corrects our substantially equivalent letter of May 27, 2004.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{3}------------------------------------------------
- machine1/FDA1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that vour device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding os substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.
| 21 CFR 876.xxx | (Gastroenterology/Renal/Urology) | (240) 276-0115 |
|---|---|---|
| 21 CFR 884.xxx | (Obstetrics/Gynecology) | (240) 276-0115 |
| 21 CFR 892.xxx | (Radiology) | (240) 276-0120 |
| Other | (240) 276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufactures, International and Consumer Assistance at its toll-free number (800) 638-2041 .or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry.suppot/index.html.
Sincerely yours,
Habd Leeman
Janine M. Morris Acting Director, Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
K04/27d
General Electric Medical Systems
STATEMENT OF INDICATION FOR USE
Device name: CT Colonography II
Indication for Use:
CT Colonography II is a CT image analysis software package which allows the visualization of 2D and 3D medical image data of the colon derived from DICOM 3.0 compliant CT scans for the purpose of screening of a colon to detect polyps, masses, cancers, and other lesions. It provides functionality for 2D/3D rendering, bookmarking of suspected lesions, synchronized viewing of the 2D, 3D and 360 dissection views, and an object oriented endoluminal display. In comparison to Colonoscopy, this tool has an advantage of depth penetration due to its 3D presentation capability. It is intended for use by Radiologists, Clinicians, and referring Physicians to process, render, review, archive, print and distribute colon image studies.
(PL)EASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) -OR-Over-The-Counter Use Prescription Use (Per 21 CFR 801.109) Division Sinn. Division of Reprod and Radiological Dev 510(k) Number 3
1/1
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).